Inhibition of fatty acid oxidation enhances oxidative protein folding and protects hepatocytes from endoplasmic reticulum stress

Molecular Biology of the Cell

Volumn 23, Issue 5, 2012, Pages 811-819

  Tyra, Heather M ^a   Spitz, Douglas R ^a   Rutkowskia, D Thomas ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ETOMOXIR; FATTY ACID; GLUTATHIONE; PENTOSE PHOSPHATE; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FATTY ACID OXIDATION; LIVER CELL; LIVER CELL CULTURE; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROTEIN FOLDING; UNFOLDED PROTEIN RESPONSE;

ACETYLCYSTEINE; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS; GLUTATHIONE; HEPATOCYTES; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PROTEIN FOLDING; RATS; UNFOLDED PROTEIN RESPONSE;

EID: 84857837547     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-12-1011     Document Type: Article

References (43)

1. Bulleid NJ, Ellgaard L (2011). Multiple ways to make disulfides. Trends Biochem Sci 36, 485-492.
2. Duvel K et al. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39, 171-183.
3. Gordon G, Mackow MC, Levy HR (1995). On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase. Arch Biochem Biophys 318, 25-29.
4. Hietakangas V, Cohen SM (2009). Regulation of tissue growth through nutrient sensing. Annu Rev Genet 43, 389-410.
5. Hotamisligil GS (2010). Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917.
6. Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao MS, Zhu Y, Borensztajn J, Reddy JK (2011a). Sustained activation of PPAR{alpha} by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J Oct 18, doi: 10.1096/fj.11-194019 [Epub ahead of print].
7. Huang J et al. (2011b). Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol 179, 703-713.
8. Lai CW, Aronson DE, Snapp EL (2010). BiP availability distinguishes states of homeostasis and stress in the endoplasmic reticulum of living cells. Mol Biol Cell 21, 1909-1921.
9. Lavery GG et al. (2008). Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. J Biol Chem 283, 8453-8461.
10. Lee AH, Scapa EF, Cohen DE, Glimcher LH (2008). Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320, 1492-1496. (Pubitemid 351929428)
11. Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR, Tabas I (2009). Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol 186, 783-792.
12. Luo S, Lee AS (2002). Requirement of the p38 mitogen-activated protein kinase signalling pathway for the induction of the 78 kDa glucoseregulated protein/immunoglobulin heavy-chain binding protein by azetidine stress: activating transcription factor 6 as a target for stress-induced phosphorylation. Biochem J 366, 787-795.
13. Malhotra JD, Miao H, Zhang K, Wolfson A, Pennathur S, Pipe SW, Kaufman RJ (2008). Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc Natl Acad Sci USA 105, 18525-18530.
14. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D (2004). CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18, 3066-3077. (Pubitemid 39658175)
15. Merksamer PI, Trusina A, Papa FR (2008). Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell 135, 933-947.
16. Merrill CL et al. (2002). Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. Toxicol Sci 68, 93-101. (Pubitemid 34785233)
17. Nadanaka S, Okada T, Yoshida H, Mori K (2007). Role of disulfide bridges formed in the luminal domain of ATF6 in sensing endoplasmic reticulum stress. Mol Cell Biol 27, 1027-1043. (Pubitemid 46174565)
18. Oosterveer MH, Grefhorst A, van Dijk TH, Havinga R, Staels B, Kuipers F, Groen AK, Reijngoud DJ (2009). Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem 284, 34036-34044.
19. Oyadomari S, Harding HP, Zhang Y, Oyadomari M, Ron D (2008). Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7, 520-532. (Pubitemid 351729207)
20. Özcan U, Özcan L, Yilmaz E, Duvel K, Sahin M, Manning BD, Hotamisligil GS (2008). Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29, 541-551. (Pubitemid 351384644)
21. Pfaffenbach KT, Nivala AM, Reese L, Ellis F, Wang D, Wei Y, Pagliassotti MJ (2010). Rapamycin inhibits postprandial-mediated X-box-binding protein-1 splicing in rat liver. J Nutr 140, 879-884.
22. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M (2010). Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 1807, 726-734.
23. Ron D, Walter P (2007). Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8, 519-529. (Pubitemid 46985379)
24. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D, Kaufman RJ (2006). Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 4, e374.
25. Rutkowski DT, Hegde RS (2010). Regulation of basal cellular physiology by the homeostatic unfolded protein response. J Cell Biol 189, 783-794.
26. Rutkowski DT et al. (2008). UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell 15, 829-840.
27. Seefeldt T, Zhao Y, Chen W, Raza AS, Carlson L, Herman J, Stoebner A, Hanson S, Foll R, Guan X (2009). Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem 284, 2729-2737.
28. Shelness GS, Sellers JA (2001). Very-low-density lipoprotein assembly and secretion. Curr Opin Lipidol 12, 151-157. (Pubitemid 32242922)
29. Sies H, Brigelius R, Wefers H, Muller A, Cadenas E (1983). Cellular redox changes and response to drugs and toxic agents. Fundam Appl Toxicol 3, 200-208. (Pubitemid 14241863)
30. Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ, Spitz DR (2007). 2-Deoxyd- glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res 67, 3364-3370. (Pubitemid 46724876)
31. Tan SX, Teo M, Lam YT, Dawes IW, Perrone GG (2009). Cu, Zn superoxide dismutase and NADP(H) homeostasis are required for tolerance of endoplasmic reticulum stress in Saccharomyces cerevisiae. Mol Biol Cell 20, 1493-1508.
32. Vickers AE, Bentley P, Fisher RL (2006). Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices. Toxicol In Vitro 20, 1173-1182. (Pubitemid 44067372)
33. Wamelink MM, Struys EA, Jakobs C (2008). The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis 31, 703-717.
34. Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufma RJ, Prywes R (2000). Activation of ATF6 and an ATF6 binding site by the endoplasmic reticulum stress response. J Biol Chem 275, 27013-27020.
35. Wang Y, Vera L, Fischer WH, Montminy M (2009). The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 460, 534-537.
36. Weis BC, Cowan AT, Brown N, Foster DW, McGarry JD (1994). Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 269, 26443-26448.
37. Wu J, Rutkowski DT, Dubois M, Swathirajan J, Saunders T, Wang J, Song B, Yau GD, Kaufman RJ (2007). ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev Cell 13, 351-364. (Pubitemid 47308675)
38. Xu HE et al. (2002). Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415, 813-817. (Pubitemid 34150506)
39. Xu J, Chang V, Joseph SB, Trujillo C, Bassilian S, Saad MF, Lee WN, Kurland IJ (2004). Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/ pentose gene expression and substrate cycle flux. Endocrinology 145, 1087-1095. (Pubitemid 38280987)
40. Yamamoto K, Takahara K, Oyadomari S, Okada T, Sato T, Harada A, Mori K (2010). Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol Biol Cell 21, 2975-2986.
41. Yuan L, Kaplowitz N (2009). Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med 30, 29-41.
42. Zhao Y, Seefeldt T, Chen W, Wang X, Matthees D, Hu Y, Guan X (2009). Effects of glutathione reductase inhibition on cellular thiol redox state and related systems. Arch Biochem Biophys 485, 56-62.
43. Zhou G et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167-1174. (Pubitemid 32995375)